Release date: 14 April 2011
Promoter – Financial Intermediary
EBG MedAustron GmbH
Location
Description
The project concerns the design, construction and operation of a hadrontherapy centre, the purpose of which is to undertake systematic clinical and non-clinical research into the use of proton and ion therapy in the treatment of cancer.
Objectives
The project could contribute to much needed clinical research on the efficacy of proton and ion therapy as treatment options for cancer.
Sector(s)
Proposed EIB finance (Approximate amount)
Up to EUR 100 million
Total cost (Approximate amount)
Up to EUR 200 million
Environmental aspects
The promoter has indicated that, according to Austrian law, an Environmental Impact Assessment is required for the construction of new particle accelerators providing energies of more than 50MeV. Since the MedAustron accelerator exceeds this threshold, an environmental impact assessment has been requested by the local authority and was approved on 20th January 2011. The environmental impact of the project, as well as the EIA process will be assessed during appraisal.
Procurement
The promoter will follow public procurement rules. Procurement procedures being followed will be verified during appraisal.
Status
Signed - 18/10/2011
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).